00:00In this study we have evaluated the economic impact of anticipating highly effective therapies.
00:08in the treatment of patients with multiple sclerosis, broadening the perspective, considering a social perspective
00:15linked not only to the loss of patient productivity, but also to the impact of the lack of work activity on the related industries.
00:24So we have valued indirect costs with the classic approach, but we have also seen what the impact on the
00:34company in terms of induced effects
00:35and therefore a more comprehensive impact to actually understand the scope of the investment and the return on investment of the advance
00:44of highly effective therapy.